Cite
MLA Citation
Jan A. Burger et al.. “Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies.” British journal of haematology, vol. 186, 2019, pp. 175–180. http://access.bl.uk/ark:/81055/vdc_100117762052.0x000064